4.2 Article

Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge

期刊

ARCHIVOS DE BRONCONEUMOLOGIA
卷 58, 期 2, 页码 142-149

出版社

ELSEVIER ESPANA SLU
DOI: 10.1016/j.arbres.2021.08.014

关键词

COVID-19 sequelae; Fibrotic changes; Lung diffusion; Serum biomarkers; Interstitial lung disease; Chest CT

资金

  1. Institute of Health Carlos III [COV20/01209]
  2. Ministry of Science and Innovation of Spain

向作者/读者索取更多资源

This study evaluated functional respiratory parameters, changes in chest CT, and correlation with peripheral blood biomarkers involved in lung fibrosis at two and six months after SARS-CoV-2 pneumonia. The results showed that almost half of patients with moderate or severe COVID-19 pneumonia had impaired pulmonary diffusion six months after discharge. Severe patients showed fibrotic lesions in CT scan and elevated serum biomarkers involved in pulmonary fibrosis.
Introduction: Impairment in pulmonary function tests and radiological abnormalities are a major concern in COVID-19 survivors. Our aim is to evaluate functional respiratory parameters, changes in chest CT, and correlation with peripheral blood biomarkers involved in lung fibrosis at two and six months after SARS-CoV-2 pneumonia. Methods: COVID-FIBROTIC (clinicaltrials.gov NCT04409275) is a multicenter prospective observational cohort study aimed to evaluate discharged patients. Pulmonary function tests, circulating serum biomarkers, chest radiography and chest CT were performed at outpatient visits. Results: In total, 313, aged 61.12 +/- 12.26 years, out of 481 included patients were available. The proportion of patients with DLCO < 80% was 54.6% and 47% at 60 and 180 days. Associated factors with diffusion impairment at 6 months were female sex (OR: 2.97, 95%CI 1.74-5.06, p = 0.001), age (OR: 1.03, 95% CI: 1.01-1.05, p = 0.005), and peak RALE score (OR: 1.22, 95% CI 1.06-1.40, p = 0.005). Patients with altered lung diffusion showed higher levels of MMP-7 (11.54 +/- 8.96 vs 6.71 +/- 4.25, p = 0.001), and periostin (1.11 +/- 0.07 vs 0.84 +/- 0.40, p = 0.001). 226 patients underwent CT scan, of whom 149 (66%) had radiological sequelae of COVID-19. In severe patients, 68.35% had ground glass opacities and 38.46% had parenchymal bands. Early fibrotic changes were associated with higher levels of MMP7 (13.20 +/- 9.20 vs 7.92 +/- 6.32, p = 0.001), MMP1 (10.40 +/- 8.21 vs 6.97 +/- 8.89, p = 0.023), and periostin (1.36 +/- 0.93 vs 0.87 +/- 0.39, p = 0.001). Conclusion: Almost half of patients with moderate or severe COVID-19 pneumonia had impaired pulmonary diffusion six months after discharge. Severe patients showed fibrotic lesions in CT scan and elevated serum biomarkers involved in pulmonary fibrosis. (C) 2021 SEPAR. Published by Elsevier Espana, S.L.U. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据